Imaging infection/inflammation in the new millennium

被引:146
作者
Rennen, HJJM [1 ]
Boerman, OC [1 ]
Oyen, WJG [1 ]
Corstens, FHM [1 ]
机构
[1] Univ Nijmegen, Med Ctr, Dept Nucl Med, NL-6500 HB Nijmegen, Netherlands
关键词
imaging; infection; inflammation; gamma scintigraphy; FDG-PET;
D O I
10.1007/s002590000447
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
In the closing half of the past century a wide variety of approaches were developed to visualise infection and inflammation by gamma scintigraphy. Use of autologous leucocytes, labelled with indium-111 or technetium-99m, is still considered the "gold standard" nuclear medicine technique for the imaging of infection and inflammation. However, the range of radiopharmaceuticals used to investigate infectious and non-microbial inflammatory disorders is expanding rapidly. Developments in protein/peptide chemistry and in radiochemistry should lead to agents with very high specific activities. Recently, positron emission tomography with fluorine-18 fluorodeoxyglucose has been shown to delineate infectious and inflammatory foci with high sensitivity. The third millennium will witness a gradual shift from basic (non-specific) or cumbersome, even hazardous techniques (radiolabelled leucocytes) to more sophisticated approaches. Here a survey is presented of the different approaches in use or under investigation.
引用
收藏
页码:241 / 252
页数:12
相关论文
共 98 条
[61]   THE UTILITY OF [TC-99M] HMPAO-LEUKOCYTES FOR IMAGING INFECTION [J].
PETERS, AM .
SEMINARS IN NUCLEAR MEDICINE, 1994, 24 (02) :110-127
[62]  
PETERS AM, 1986, LANCET, V2, P945
[63]   Imaging inflammation with Tc-99(m)-labelled chemotactic peptides: Analogues with reduced neutropenia [J].
Pollak, A ;
Goodbody, AE ;
Ballinger, JR ;
Duncan, GS ;
Tran, LL ;
DunnDufault, R ;
Meghji, K ;
Lau, F ;
Andrey, TW ;
Boxen, I ;
SumnerSmith, M .
NUCLEAR MEDICINE COMMUNICATIONS, 1996, 17 (02) :132-139
[64]  
RENNEN HJJ, 2001, IN PRESS J NUCL MED
[65]   Cytokines in inflammatory bowel disease [J].
Rogler, G ;
Andus, T .
WORLD JOURNAL OF SURGERY, 1998, 22 (04) :382-389
[66]  
ROITT IM, 1997, ESSENTIAL IMMUNOLOGY
[67]  
Rusckowski M, 1996, J NUCL MED, V37, P1655
[68]  
Rypins EB, 2000, AM SURGEON, V66, P891
[69]  
SAKAHARA H, 1989, J NUCL MED, V30, P1311
[70]  
Samuel A, 1996, J NUCL MED, V37, P55